Analyst Gary Lieberman is focused on the Healthcare sector with 8 price targets and ratings documented since 2017 spanning on 2 stocks. Previously, Gary Lieberman worked at WELLS FARGO. Analyst's average stock valuation to be materialised ratio is 100% with an average time for price targets to be met of 28 days.
Most recent stock forecast was given on DGX, Quest Diagnostics Incorporated at 20-Oct-2017.
Gary Lieberman best performing recommendations are on DGX (QUEST DIAGNOSTICS INCORPORATED).
The best stock recommendation documented was for DGX (QUEST DIAGNOSTICS INCORPORATED) at 10/12/2017. The price target of $88 was fulfilled within 49 days with a profit of $5.66 (6.87%) receiving and performance score of 1.4.
Average potential price target upside
Currently, out of the existing stock ratings of Gary Lieberman - 770 which are a Hold (68.44%), 190 which are a Sell (16.89%), 165 which are a Buy (14.67%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
165
$24.94 (17.81%)
165
10 days ago
26/30 (86.67%)
$17.35 (20.46%)
383
Hold
160
$19.94 (14.24%)
160
10 days ago
9/12 (75%)
$18.8 (18.11%)
268
Hold
154
$13.94 (9.95%)
146
2 months 15 days ago
11/13 (84.62%)
$20.35 (20.09%)
330
Hold
158
$17.94 (12.81%)
146
2 months 21 days ago
19/20 (95%)
$15.12 (15.48%)
226
Hold
140
$-0.06 (-0.04%)
129
5 months 6 days ago
15/16 (93.75%)
$17.88 (26.92%)
885
